📣#VivetTherapeutics is headed to the land down under!📣

Join our Co-Founder and CSO, Dr @Gloria Gonzalez-Aseguinolaza at the Australasian Gene and Cell Therapy Society (#ASGCT) Biennial Meeting in Sydney, Australia from 30 October – 1 November.

Don’t miss this excellent opportunity to listen👂in as Gloria provides insight into gene editing for the treatment of inherited liver disorders.

📢 Session 1: Gene and molecular therapies

🎤 Presentation Title: Gene editing for the treatment of inherited liver disorders

📅 Date: Wednesday 30 October 2024

🕘 Time: 9.50-10.30 AEDT

💬 Connect with🤝Gloria onsite to learn more about our diversified pipeline of novel and long-lasting # rAAV-based gene therapies for rare inherited liver metabolic disorders.

📲 Follow @Vivet Therapeutics on LinkedIn and on X @ Vivet_tx to stay up to date with our latest developments!